Buscar
Mostrando documentos 1-6 de 6
Strategies and advances in combating COVID-19 in China
Coronavirus disease 2019 (COVID-19)—the third in a series of coronavirus infections—has caused a global public health event in the 21st century, resulting in substantial global morbidity and mortality. Building on its ...
Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines
Several live-attenuated viral vaccine candidates are among the COVID-19 vaccines in development. The
Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe ...
Transforming vaccine development
The urgency to develop vaccines against Covid-19 is putting pressure on the long and expensive development
timelines that are normally required for development of lifesaving vaccines. There is a unique opportunity to ...
Development of a novel platform of virus-like particle (VLP) based vaccine against coronavirus 2019 (SARS-CoV-2) by exposing of epitopes: an immunoinformatics approach
The emergence of a rapidly spreading and highly infectious COVID-19 outbreak by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has caused a global pandemic with unprecedented, social and ...
Contingent assessment of the COVID-19 vaccine
The COVID-19 pandemic has not only had a negative impact on people’s health and life behavior, but also
on economies around the world. At the same time, laboratories and institutions are working hard to
obtain a COVID-19 ...
Prevention and treatment of COVID-19: focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
The ongoing pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) has drawn the attention of researchers and clinicians from several disciplines and sectors
who are trying to find durable ...